Sagility Limited · NSE:SAGILITY
Sagility — Q2 FY27 Earnings Presentation
21 slides from Sagility's earnings presentation, Oct 22, 2026
Slide 1: Submission of Investor Presentation to NSE and BSE
Date: October 22, 2026 To, To, The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited (NSE) BSE Limited (BSE) Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C/1, G-Block Dalal Street Mumbai - 400 001 Bandra-Kurla Complex Scrip Code:544282
Slide 2: Investor Deck – Q2 FY27
Investor Deck – Q2 FY27 Oct 22, 2026
Slide 3: Safe Harbor
Safe Harbor Certain statements in this release concerning Sagility’s future growth prospects may be seen as forward-looking statements, which involve a number of risks and uncertainties that could cause the actuals to differ materially from such statements. Sagility does not undertake to update any
Slide 4: Performance Highlights
Performance Highlights Q2 FY27 Business Insights H1 FY27 ▶ 11.9% Y-o-Y Constant currency organic growth in Q2 FY27, driven by expansion within national payers and mid market Adjusted Adjusted clients Adjusted Adjusted Revenue Revenue EBITDA PAT EBITDA PAT ▶ Won $40.2 M of ACV in Q2 FY27, from 31 exi
Slide 5: KPIs
KPIs Q2 FY27 Q1 FY27 Q2 FY26 YoY% H1 FY27 H1 FY26 YoY% Revenue from Operation (in ₹ M) 20,321 19,635 16,585 22.5% 39,956 31,974 25.0% Steady state Revenue 20,321 19,635 16,585 22.5% 39,956 31,974 25.0% Seasonal Revenue (Open Enrollment/AEP) - - - - - - - Revenue by Vertical Split By Payer 89.9% 89.6
Slide 6: Annual KPIs
Annual KPIs H1 FY27 FY26 FY25 FY24 FY23 Numbers of Client group Active 105 82 75 44 35 Number of new client addition (Gross) 28** 17 38 13 7 Delivery Sites Number of delivery sites 28 31 33 30 27 New site addition (Gross) - 4 10 4 2 TTM Sep26 FY26 FY25 FY24 FY23 Client groups contribution to revenue
Slide 7: Comprehensive end-to-end Provider RCM solution
+ Comprehensive end-to-end Provider RCM solution
Slide 8: Chirok strengthens Sagility's provider footprint
Chirok strengthens Sagility’s provider footprint Founded in 2020 and headquartered in Nashville, Chirok Health is a specialized provider of Clinical Documentation Improvement (CDI) solutions. The company complements its core CDI offerings with adjacent solutions, including medical coding, RAC, and H
Slide 9: Chirok bridges the CDI and coding gap
Chirok bridges the CDI and coding gap, enabling Sagility to offer more comprehensive end-to-end provider revenue solutions Sagility Chirok core Combined scope Sagility Sagility Patient Clinical Documentation Billing Clinical denials A/R & access & coding & claims & appeals collections Growth opportu
Slide 10: Marketing & Thought Leadership
Marketing & Thought Leadership AI & Intelligent Operations Healthcare Perspectives Research & Insights Sagility Synchrony SmarTec White Paper Solutions Future-Proofing Advisor, Healthcare Payer Sasha Operations with Intelligence Provider Services Case Studies HealthBridge Connect SmarTec Voice Agent
Slide 11: Financial Highlights
Financial Highlights Nsagility
Slide 12: Financial Highlights
Financial Highlights Q2 FY27 H1 FY27 Adjusted Adjusted Adjusted Adjusted Revenue OCF Revenue OCF EBITDA PAT EBITDA PAT ₹ 20,321 ₹ 5,353 ₹ 3,254 ₹ 3,182 ₹ 39,956 ₹ 10,069 ₹ 5,951 ₹ 6,343 Million Million Million Million Million Million Million Million YoY growth YoY growth Margin % Margin % Conversion
Slide 13: Quarterly Seasonality: Revenue Mix and Adjusted EBITDA Margin
Quarterly Seasonality Revenue Mix and Adjusted EBITDA Margin % $181.8 $172.0 $10.3 Includes 3 $9.7 month of Adjusted EBITDA Margin 2 months of BroadPath 28.4% BroadPath revenue 26.6% Revenue ($11.3M) Revenue ($M) 26.1% 26.2% ($8.9M) 24.0% $189.4 $157.9 $162.3 $171.5 $180.4 Q2 FY25 Q3 FY25 Q4 FY25 Q1
Slide 14: Long Term Financial Performance Snapshot
Long Term Financial Performance Snapshot FY25 FY26 Adj. EBITDA* (₹M) FY25 FY26 Adj. PAT(₹M) FY25 FY26 Revenue (₹M) (growth % Y-o-Y) 17.2% 29.1% (growth % Y-o-Y) 28.4% 23.9% (growth % Y-o-Y) 37.5% 39.5% ₹79,910 ₹71,929 ₹55,699 ₹20,229 ₹47,536 ₹18,200 ₹14,685 ₹11,306 ₹12,250 ₹11,436 ₹8,107 ₹5,896 FY24
Slide 15: Other Financial Indicators
Other Financial Indicators Adjusted EPS (in ₹) Adjusted ROCE % 2.62 2.42 58.9% 54.9% 55.4% 1.76 47.0% 1.38 FY24 FY25 FY26 TTM Sep26 FY24 FY25 FY26 TTM Sep26 Cash Conversion (%) 1.90x Net Debt 87.2% 89.7% 0.71x ₹30,000 80.5% 70.8% ₹25,000 ₹21,678 64.7% 64.9% 54.4% ₹20,000 0.11x 52.9% ₹15,000 ₹10,433
Slide 16: Q2 FY27 Consolidated Profit and Loss
Q2 FY27 Consolidated Profit and Loss Amount in ₹ M Particulars Q2 FY27 Q1 FY27 Q2 FY26 YoY% QoQ% H1 FY27 H1 FY26 YoY% Revenue from Operation 20,321 19,635 16,585 22.5% 3.5% 39,956 31,974 25.0% Steady state Revenue 20,321 19,635 16,585 22.5% 3.5% 39,956 31,974 25.0% Seasonal Revenue (Open Enrollment)
Slide 17: Adjustments on EBITDA and PAT
Adjustments on EBITDA and PAT Adj EBITDA Bridge: Q2 FY27 (₹M) Adj EBITDA Bridge: H1 FY27 (₹M) ₹9,776 ₹19 ₹76 ₹198 ₹10,069 ₹5,252 ₹27 ₹16 ₹58 ₹5,353 Reported Other income/ Adjusted Reported Other income/ Adjusted Adj A Adj B Adj A Adj B EBITDA FX gain EBITDA EBITDA FX gain EBITDA Adj PAT Bridge: Q2 F
Slide 18: Go Forward Positions
Go Forward Positions Amt in ₹ M Particulars FY26 FY27 FY28 FY29 FY30 FY31 FY32 Closing Debt position 5,670 - - - - - - Debt Repayment 2,350 5,670 - - - - - Interest Payment 543 287 - - - - - Share based Payment awards 122 136 74 39 - - - Earnouts Cost 475 67 96 19 - - - Intangibles Amortisation (A)
Slide 19: Balance Sheet – 30th Sep 26
Balance Sheet – 30th Sep 26 Amt in ₹ M Particulars Sep 26 Mar 26 Property, plant and equipment 4,644 4,624 Right-of-use assets 4,250 4,868 Goodwill 66,085 64,051 Other intangible assets 20,323 20,407 Trade receivables and unbilled 17,753 18,390 Cash and cash equivalents (including investments) 10,06
Slide 20: Cash Flow – H1 FY27
Cash Flow – H1 FY27 Amt in ₹ M Particulars H1 FY27 FY26 Profit before tax for the period/ year 6,617 12,389 Adjustment for Non-Operating and Non-Cash items 2,970 5,271 Adjustment for working capital (1,082) (1,895) Income taxes paid (net of refunds) (2,162) (3,735) Net cash flows generated from oper
Slide 21: Thank you
SR sagility Thank you @) © © ©